ARDT
ANALYST COVERAGE11 analysts
BUY
+46.6%upside to target
L $12.00
Med $13.00consensus
H $14.00
Buy
873%
Hold
218%
Sell
19%
8 Buy (73%)2 Hold (18%)1 Sell (9%)
Full report →
PRICE
Prev Close
9.21
Open
9.26
Day Range8.80 – 9.26
8.80
9.26
52W Range8.28 – 16.19
8.28
16.19
7% of range
VOLUME & SIZE
Avg Volume
558.8K
FUNDAMENTALS
P/E Ratio
6.0x
Value territory
EPS (TTM)
Div Yield
No dividend
TECHNICAL
RSI (14)
43
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 105 days
Aug 31
Key MetricsTTM
Market Cap$1.45B
Revenue TTM$6.43B
Net Income TTM$134.28M
Free Cash Flow$213.81M
Gross Margin49.7%
Operating Margin9.0%
Net Margin2.1%
Return on Equity9.1%
Return on Assets2.6%
Debt / Equity0.70
Current Ratio2.12
EPS TTM$0.95

ARDT News

About

No description available.

Jason EhrlinspielChief Compliance Officer
Frank J. CampbellChief Medical Officer
Alfred LumsdaineChief Financial Officer
David ByersSenior Vice President & Chief Accounting Officer
Kevin J. Gross FACHERegional President of Oklahoma Region
David Anthony StybloSenior Vice President of Investor Relations
David CaspersChief Operating Officer
Donald BakerRegional President of Lone Star Region
Ethan CherninPresident of Health Services
Lonnie GarrisonChief Technology Officer
Martin J. Bonick FACHEPresident, Chief Executive Officer & Director
Robert CoscioneSenior Vice President of Payor Strategies
Stephen Christopher PetrovichExecutive Vice President, Chief Legal Officer & Secretary